Wintrust Investments’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-740
Closed -$69K 460
2024
Q3
$69K Sell
740
-7,098
-91% -$596K 0.05% 269
2024
Q2
$611K Buy
7,838
+237
+3% +$19.3K 0.05% 264
2024
Q1
$691K Buy
7,601
+377
+5% +$31.4K 0.06% 239
2023
Q4
$559K Buy
7,224
+1,621
+29% +$114K 0.05% 257
2023
Q3
$381K Sell
5,603
-25
-0.4% -$1.82K 0.04% 298
2023
Q2
$457K Sell
5,628
-14
-0.2% -$1.12K 0.05% 275
2023
Q1
$463K Buy
+5,642
New +$403K 0.06% 219

Other funds holding GEHC

Wintrust Investments's GEHC Position: Q4 2024 in Review

Wintrust Investments sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 740 shares — an estimated $69K sold.

Wintrust Investments first reported a position in GEHC in Q1 2023 and held it in 7 quarters. The position peaked at $691K in Q1 2024. 1,326 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

  • Wintrust Investments reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
  • Wintrust Investments sold 740 GE HealthCare shares in Q4 2024, an estimated $69K.
  • Wintrust Investments first reported a position in GE HealthCare in Q1 2023 and held it in 7 quarters.
  • Wintrust Investments's GE HealthCare position peaked at $691K in Q1 2024.
  • 1,326 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.